Do you have a specific policy for anesthesia providers that governs the transport of personal items into the OR suite (i.e., briefcases, personal computers, backpacks) in an ambulatory surgery center and/or hospital OR? The concern is not only infection control but risk for diversion. Looking for feedback on how this has been addressed.

For those of you with Epic, do you have any tips/templates to share when using admin criteria for lengthy instruction? Specifically, our system is struggling with heparin infusion titrations and insulin infusion titrations. Font is fixed, no options for bold, italic, color etc, so when you have a large amount of information, it's challenging for nurses to sift through. Any advice or examples would be much appreciated.

Hello. Does anyone who is live with IV pump/EMR interoperability have experience with switching pump vendors? I'm wondering specifically if you had to go through a period of downtime (greater than a few hours) with interoperability when the new pumps were brought on board or if you were able to maintain interop functionality throughout the transition. Any additional tips on the transitions would also be much appreciated.

Hello and good morning everyeone. Our institution will be transitioning from medications being charged on dispense (COD) to charge on administration (COA). Have any institutions made this transition in the past? Looking for any commentary or feedback on your experience(s).

Thanks in advance.

The storage information for montelukast in both Lexicomp and the package insert says to keep in original container until use. For facilities that order bulk bottles of the 4mg chew, 5mg chew or 10mg tabs, how are you dispensing to patients? Are you truly keeping in original bottle and dispensing individually to each patient? Or trying to keep U/D in stock?

Hello colleagues,

I am seeking input from other institutions regarding how intraventricular medications (e.g.,alteplase, vancomycin, gentamicin) are prepared at your facility, and whether any additional practices or processes are in place around the delivery of these medication to the end user which may differ from other sterile compound products.

Thank you in advance for your time and collaboration.

Matt

My organization has recently been approached by Hikma representatives regarding Tyzavan. Some of you may recall the Vanco Ready or "Xellia" premix bags of vancomycin (NDC 70594-041-01, among others), which were acquired by Hikma a while back. These products have an advantage as room temperature premixes of vancomycin, which is fairly unique.

Checking to see if anyone has used vial to bag adapters for administration of 500 mg daptomycin?

What requirements do you have for administration of Rhogam in the ambulatory setting?

Are LPNs/MAs allowed to administer via IM injection?

Thank you!

Hi,

I'd like to know how other organizations comply (or planning to comply) with the new Joint Commission requirement in the Medication Management Chapter (effective 1/1/2026).

It states:
The hospital has a method (such as using established benchmarks for the size and scope of services provided by the hospital or studies on reporting rates published in peer-reviewed journals) by which to measure the effectiveness of its process for identifying and reporting medication errors and adverse drug reactions to the quality assessment and performance improvement program.